Related Experiment Videos
An observational study on the effects of nadroparin-based and citrate-based continuous venovenous hemofiltration on
Peter H J van der Voort1, Sonja R Postma, W Peter Kingma
1Department of Intensive Care, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. phjvdvoort@chello.nl
Insights
Citrate continuous venovenous hemofiltration (CVVH) in critically-ill patients temporarily lowers serum ionized calcium (iCa) and negatively impacts calcium balance, increasing parathyroid hormone (PTH). Nadroparin showed no such effects.
Area of Science:
- Nephrology
- Intensive Care Medicine
- Critical Care
Background:
- Acute renal failure (ARF) management often requires continuous venovenous hemofiltration (CVVH).
- Calcium homeostasis is crucial in critically-ill patients undergoing CVVH.
- Anticoagulation strategies, such as citrate or nadroparin, may influence calcium balance.
Purpose of the Study:
- To compare calcium homeostasis during citrate-based versus nadroparin-based CVVH in critically-ill patients with ARF.
- To evaluate the impact of citrate CVVH on serum ionized calcium (iCa) and calcium balance.
- To assess the effect on parathyroid hormone (PTH) levels.
Main Methods:
- Observational study involving 11 patients on citrate CVVH, 9 on nadroparin CVVH, and 10 controls.
- Citrate anticoagulation was selected for patients with bleeding risk.
- Serum iCa, calcium balance, and PTH levels were monitored.
Main Results:
- Citrate CVVH patients exhibited significantly lower serum iCa at 24 hours (0.87 mmol/l) compared to controls (1.1 mmol/l) and nadroparin (1.1 mmol/l).
- Calcium balance was negative in the citrate group, unlike the nadroparin group.
- Median serum PTH was significantly higher in the citrate group (30.0 pmol/l) versus controls (6.5 pmol/l).
Conclusions:
- Citrate CVVH, with a target iCa of 0.8-0.9 mmol/l, leads to negative calcium balance and transient hypocalcemia.
- This hypocalcemia in citrate CVVH patients results in an enhanced PTH response compared to nadroparin.
- Careful monitoring of calcium levels and balance is essential during citrate CVVH.
Background:
To study calcium homeostasis during citrate-based compared to nadroparin-based CVVH in critically-ill patients with acute renal failure.
Methods:
11 patients were observed during citrate anticoagulation, 9 with nadroparin and 10 controls. Citrate was chosen for patients with active or at risk for bleeding.
Results:
The controls had, at 24 h, a median serum iCa of 1.1 mmol/l, the citrate group 0.87 mmol/l and the nadroparin group 1.1 mmol/l (citrate vs. control p = 0.001, citrate vs. nadroparin p = 0.002). At 48 h, iCa was not significantly different anymore. Ca balance was negative for the citrate group in contrast to the nadroparin group (p = 0.012). Median serum PTH was higher (30.0 pmol/l vs. 6.5 pmol/l, p = 0.003) in the citrate group.
Conclusion:
With a relative low target-serum-iCa (0.8-0.9 mmol/l) citrate CVVH-treated patients had a negative daily calcium balance and a temporarily lower iCa level resulting in an enhanced PTH response in comparison to nadroparin.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins